top of page
HeroHome.jpg

It May Not be "Just" Constipation

1 in 5 women have Obstructed
 Defecation Syndrome (ODS)

ODiSi™ is not currently FDA cleared for ODS. The content of the website is provided for informational purposes only.​

Click here to stay up to date. 

Women are talking about ODS

Women with ODS is a group for women to share their unique experiences in a private, positive community. Spread awareness and peace of mind by adding your voice. 

info@altyxmedical.com

Altyx has developed groundbreaking new technologies, for frequently ignored women’s pelvic health conditions including the first minimally invasive solution for female obstructed defecation.

Altyx Media

Altyx Updates

Breakthrough Device Designation 

ODiSi™, a new type of treatment for ODS, has received FDA Breakthrough Device Designation, which is awarded to devices with the potential for "significant advantages over existing approved or cleared alternatives to include reducing or eliminating the need for hospitalization, improving patient quality of life, facilitating the patients’ ability to manage their own care or establishing long-term clinical efficiencies”.

Altyx Update:

National Science Foundation

SBIR Phase I & II:

National Science Foundation SBIR Phase I & II awarded for "mesh free, sling free, minimally invasive treatment for stress urinary incontinence."

Altyx Update:

Altyx in the Press

Photo-by-Imani-Bahati-on-Unsplash-770x513.jpg

Giving Women Their Bodies Back: Many Post-Pregnancy Pelvic Health Problems Can Be Treated in Less Than an Hour — A Top Doctor Explains 
In this interview with Better Magazine, Dr. Roger Goldberg discusses some of the most common female Pelvic Floor Disorders like Pelvic Organ Prolapse (POP), Bladder disorders, and Obstructed Defecation Syndrome (ODS).